SAN DIEGO--(BUSINESS WIRE)--Lenetix Medical Screening Laboratory, Inc. today announced at the 55th Annual American College of Obstetricians and Gynecologists (ACOG) Meeting that it has been granted a clinical laboratory permit by the State of California. Lenetix Medical Screening Laboratory is a New York-based provider of rapid genetic risk assessment tools and diagnostic tests for clinicians worldwide, and is a key partner of Sequenom Inc. (NASDAQ: SQNM), a San Diego-based company that is developing a portfolio of non-invasive prenatal diagnostics. The notification means that Lenetix is now permitted to receive clinical samples from clients residing in California.
